Skip to content
Home/Companies/Pharma/MITEM Pharma
MITEM Pharma

MITEM Pharma

Pharma·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns MITEM Pharma?

MITEM Pharma is a French Pharma company, currently owned by TechLife Capital since 2020.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
TechLife Capital
Investor
TechLife Capital
TechLife Capital I · 2018 · Growth

Key facts

HQFrance
SectorPharma
Websitewww.mitempharma.com

More from TechLife Capital I

Other portfolio companies in the same fund.

RNAlead
RNAlead
Active
BiotechFrance· 2021
XPath
XPath
Active
HealthcareFrance· 2021
CNSI
Active
TMTFrance· 2020
Maxxing
Maxxing
Exited 2025
SaaSFrance· 2020
to Optimix Solutions
MDT
Active
TMTFrance· 2020
Venn
Active
TMTFrance· 2020

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns MITEM Pharma?

MITEM Pharma is currently owned by TechLife Capital, through TechLife Capital I, since 2020.

When did TechLife Capital acquire MITEM Pharma?

TechLife Capital acquired MITEM Pharma in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue